pisco_log
banner

Advances in Radiomics of the Tumor Microenvironment in Metastatic Lymph Nodes

Xiaofei Xu, Jianfeng Yang*

Abstract


As one of the main ways of tumor metastasis, the presence or absence of lymph node metastasis is of great significance to the choice
of treatment and prognosis of tumor patients. With significant advances in immunotherapy, assessing the tumor microenvironment in metastatic lymph nodes and predicting the efficacy of lymph node immunotherapy has become a hot research topic. In this review, we summarize the
recent radiomics studies in assessing the tumor microenvironment of metastatic lymph nodes and predicting the efficacy of immunotherapy.
We also discuss the role of metastatic lymph node stromal cells in antitumor immunity.

Keywords


Radiomics; Tumor microenvironment; Metastatic lymph nodes; Immunotherapy; Stromal cells

Full Text:

PDF

Included Database


References


[1] Comen EA. Tracking the seed and tending the soil: evolving concepts in metastatic breast cancer. Discov Med. 2012 Aug;14(75):97-

104. PMID: 22935206.

[2] Lian J, Ozga AJ, Sokol CL, Luster AD. Targeting Lymph Node Niches Enhances Type 1 Immune Responses to Immunization. Cell Rep.

2020 May 26;31(8):107679. doi: 10.1016/j.celrep.2020.107679. PMID: 32460031; PMCID: PMC7369031.

[3] Kang CY, Duarte SE, Kim HS, Kim E, Park J, Lee AD, Kim Y, Kim L, Cho S, Oh Y, Gim G, Park I, Lee D, Abazeed M, Velichko

YS, Chae YK. Artificial Intelligence-based Radiomics in the Era of Immuno-oncology. Oncologist. 2022 Jun 8;27(6):e471-e483. doi:

10.1093/oncolo/oyac036. PMID: 35348765; PMCID: PMC9177100.

[4] Meurette O, Mehlen P. Notch Signaling in the Tumor Microenvironment. Cancer Cell. 2018 Oct 8;34(4):536-548. doi: 10.1016/

j.ccell.2018.07.009. Epub 2018 Aug 23. PMID: 30146333.

[5] Zeng D, Wu J, Luo H, Li Y, Xiao J, Peng J, Ye Z, Zhou R, Yu Y, Wang G, Huang N, Wu J, Rong X, Sun L, Sun H, Qiu W, Xue Y,

Bin J, Liao Y, Li N, Shi M, Kim KM, Liao W. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of

advanced gastric cancer. J Immunother Cancer. 2021 Aug;9(8):e002467. doi: 10.1136/jitc-2021-002467. PMID: 34376552; PMCID:

PMC8356190.

[6] Jones D, Pereira ER, Padera TP. Growth and Immune Evasion of Lymph Node Metastasis. Front Oncol. 2018 Feb 21;8:36. doi: 10.3389/

fonc.2018.00036. PMID: 29527513; PMCID: PMC5829610.

[7] Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016 Feb;278(2):563-77. doi:

10.1148/radiol.2015151169. Epub 2015 Nov 18. PMID: 26579733; PMCID: PMC4734157.

[8] Xu YH, Lu P, Gao MC, Wang R, Li YY, Song JX. Progress of magnetic resonance imaging radiomics in preoperative lymph node diagnosis of esophageal cancer. World J Radiol. 2023 Jul 28;15(7):216-225. doi: 10.4329/wjr.v15.i7.216. PMID: 37545645; PMCID:

PMC10401402.

[9] Pikor NB, Cheng HW, Onder L, Ludewig B. Development and Immunological Function of Lymph Node Stromal Cells. J Immunol.

2021 Jan 15;206(2):257-263. doi: 10.4049/jimmunol.2000914. PMID: 33397739.

[10] Coroller TP, Agrawal V, Huynh E, Narayan V, Lee SW, Mak RH, Aerts HJWL. Radiomic-Based Pathological Response Prediction from

Primary Tumors and Lymph Nodes in NSCLC. J Thorac Oncol. 2017 Mar;12(3):467-476. doi: 10.1016/j.jtho.2016.11.2226. Epub 2016

Nov 27. PMID: 27903462; PMCID: PMC5318226.




DOI: http://dx.doi.org/10.70711/pmr.v2i3.5477

Refbacks

  • There are currently no refbacks.